menu-hamburger-svgrepo-com

Evolutionary history of three-finger snake toxins decoded

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Snakebites cause around 100 000 deaths worldwide every year.

Researchers at the Technical University of Munich have investigated how the toxin emerged between 50 and 120 million years ago through the modification of a gene that also occurs in mammals and other reptiles. The results could help with the development of better snakebite treatments and lead to new knowledge for the treatment of illnesses such as type 2 diabetes and hypertension.

When venom passes into a snakebite victim, it binds onto receptors on nerve and muscle cells and interrupts communication pathways between them. This initially causes paralysis and, without an antidote, can cause death within a matter of minutes or hours. A team of researchers has studied how the protein structure of snake venoms known as three-finger toxins (3FTxs) has changed over the course of evolution.

EMERGENCE OF THREE-FINGER TOXINS

The team working with Prof Burkhard Rost, a professor of bioinformatics, discovered that three-finger toxins developed over time from the Ly6 gene, which is also present in mammals and other reptiles. It is responsible for various metabolic functions such as the immune response of cells and neural regulation. Dr Ivan Koludarov, a researcher at the Chair for Bioinformatics and a first author of the study says: “It is inferred from previous studies that snakes diverged from other lizards around 120 million years ago. Present-day venomous snakes and other snake species diverged around 50 million years ago and both already carry functional 3FTx genes. That means that the Ly6 gene changed so much over the period from 50–120 million years ago that it now causes a strong toxic effect.”

In the course of evolution the Ly6 gene, which generates the instructions for the toxin, doubled repeatedly. Consequently, venomous snakes carry multiple copies of the gene. On these copies, various segments have mutated. As a result, the function of the protein encoded by the gene changed so radically that it no longer performs its original function and instead acts as a toxin.

VARIOUS FORMS OF THE VENOM

Tobias Senoner, a doctoral candidate at the Chair for Bioinformatics adds: “The gene has mutated in different ways in the various snake species. Based on the resulting protein structures, we can distinguish four forms of the 3FTx toxin. Each one has specific structures and therefore acts differently on the snake’s prey.” Prof Burkhard Rost explains:

“For our study we collected all available information from the UniProt database, which provides data on proteins of all living organisms and viruses. In addition, we accessed biomedical and genetic information from the National Center for Biotechnology Information. We analysed these data through the lens of artificial intelligence.”

IMPROVEMENTS IN TREATMENTS AND DRUG DEVELOPMENT

The insights from the study will help to improve the treatment of snakebite victims and bring about progress in drug development. The understanding of the toxins could help in the development of new treatment methods for type 2 diabetes or hypertension, for example, or better pain medications.

Suggested Articles

Suggested Clinical & CPD content

CPD: 1pt

Related articles

Welcome to Medical Academic​

Get the most out of Medical Academic by telling us your occupation. This helps us create more great content for you and the community.

idea

1000’s of Clinical and CPD content compiled by Key Opinion Leaders and our expert medical editors.

connection

Access to medical webinars and events

Group 193

Access medical journals from industry leaders and expert medical editorials.

Congratulations! Your account was successfully created.

Please check your email for an activation mail. Click the activation link to activate your account

Stay up to date

Search for anything across CPD, webinars and journals
idea

1000’s of Clinical and CPD content compiled by Key Opinion Leaders and our expert medical editors.

connection

Access to medical webinars and events

Group 193

Access medical journals from industry leaders and expert medical editorials.

Congratulations! You have successfully booked your seat.

All webinar details will be emailed to your email address.

Did you know, you can book future webinars with a single click if you register an account with Medical Academic.

Congratulations! Your account was successfully created.

Your webinar seat has been booked and all webinar details will be emailed to your registered email address

Why not register for Medical Academic while booking your seat for this webinar?

Future Medical Academic webinars can be booked with a single click, all with a Medical Academic account… and it’s FREE.

Book webinar & create your account

* (Required)

idea

1000’s of Clinical and CPD content compiled by Key Opinion Leaders and our expert medical editors.

connection

Access to medical webinars and events

Group 193

Access medical journals from industry leaders and expert medical editorials.

Congratulations! Your account was successfully created.

Thank you for registering. You can now log in to your account.

Create your account

* (Required)

Login with One Time Pin (OTP)

Enter your registered email address to receive an OTP

A verification code will be sent to your email address. Please ensure that admin@medicalacademic.co.za is on your safe sender list.

We've sent your OTP